Gateway Wealth Partners LLC Takes Position in SPDR S&P Biotech ETF $XBI

Gateway Wealth Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 11,938 shares of the exchange traded fund’s stock, valued at approximately $1,525,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Wealth Management Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 1st quarter worth about $547,000. Apella Capital LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at about $490,000. Banque Pictet & Cie SA raised its holdings in shares of SPDR S&P Biotech ETF by 24.1% during the 4th quarter. Banque Pictet & Cie SA now owns 64,877 shares of the exchange traded fund’s stock valued at $7,910,000 after buying an additional 12,595 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its position in SPDR S&P Biotech ETF by 106.9% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,570 shares of the exchange traded fund’s stock worth $3,240,000 after buying an additional 13,729 shares during the last quarter. Finally, Keystone Investors PTE Ltd. bought a new stake in SPDR S&P Biotech ETF in the 4th quarter worth approximately $12,022,000.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $149.78 on Wednesday. The firm has a market cap of $10.09 billion, a P/E ratio of 11.47 and a beta of 0.82. The stock has a 50 day simple moving average of $145.16 and a two-hundred day simple moving average of $133.90. SPDR S&P Biotech ETF has a 1 year low of $84.39 and a 1 year high of $165.71.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.